Fujifilm and Axcelead Drug Discovery Partners Begin Collaborating to Advance Drug Discovery Solutions Using IPSCS
July 11, 2019
July 11, 2019
VALHALLA, New York, July 11 -- Fujifilm USA issued the following news:
* * *
- To enhance the Process of Research and Development of Drug Candidates
* * *
FUJIFILM Corporation (President: Kenji Sukeno; Fujifilm) and Axcelead Drug Discovery Partners Inc. (President: Yoshinori Ikeura; Axcelead) announced a collaboration to provide customers with a human induced pluripotent stem cell (iPSC)-based integrated platform for drug discovery solutions. B . . .
* * *
- To enhance the Process of Research and Development of Drug Candidates
* * *
FUJIFILM Corporation (President: Kenji Sukeno; Fujifilm) and Axcelead Drug Discovery Partners Inc. (President: Yoshinori Ikeura; Axcelead) announced a collaboration to provide customers with a human induced pluripotent stem cell (iPSC)-based integrated platform for drug discovery solutions. B . . .